{
  "ticker": "JNJ",
  "timestamp": "2025-12-01T18:18:36.683029",
  "analysis_date": "2024-10-03",
  "historical_mode": true,
  "portfolio_value": 100000.0,
  "verdict": "MODIFY",
  "final_position_pct": 0.043018,
  "final_position_dollars": 4301.8,
  "confidence": "MEDIUM",
  "reasoning": "Modifying our position in Johnson & Johnson (JNJ) to 4.30% is a strategic decision that capitalizes on the current oversold conditions and the company's robust earnings growth potential. With a high confidence rating from our research manager, the favorable risk/reward ratio positions JNJ as an attractive investment opportunity that is poised for recovery. This modification aligns perfectly with our bullish outlook based on strong fundamentals and technical indicators.",
  "key_factors": [
    "strong earnings growth",
    "favorable risk/reward ratio",
    "current oversold conditions"
  ],
  "conditions": [
    "high confidence in recovery",
    "positive technical indicators"
  ],
  "stop_loss_pct": 15,
  "profit_targets": [
    12.5,
    18.8,
    25
  ],
  "guardrail_corrections": [],
  "is_llm_decision": true,
  "risk_controls": {
    "stop_loss": {
      "percentage": 15,
      "dollar_amount": 645.27
    },
    "take_profit": {
      "targets": [
        12.5,
        18.8,
        25
      ],
      "scale_out": [
        0.33,
        0.33,
        0.34
      ]
    },
    "time_limit": {
      "max_holding_period": "90 days",
      "review_frequency": "weekly"
    }
  },
  "risk_consensus": {
    "stances": {
      "aggressive": "HOLD",
      "neutral": "SMALL BUY",
      "conservative": "HOLD"
    },
    "position_sizes": {
      "aggressive": 6.5,
      "neutral": 12.0,
      "conservative": 0
    },
    "agreements": [],
    "conflicts": [
      "Mixed views: 1 buy, 0 avoid"
    ],
    "avg_position_size": 0.06166666666666667,
    "red_flags": [
      {
        "flag": "Red flag count exceeds acceptable limit",
        "severity": "LOW",
        "source": "Pre-calculated risk metrics"
      }
    ]
  },
  "position_sizing": {
    "range_min_pct": 3.0,
    "range_max_pct": 4.5,
    "final_pct": 4.3018,
    "final_dollars": 4301.8
  },
  "agent_votes": {
    "bullish": 2,
    "bearish": 0,
    "neutral": 2,
    "consensus": "LEAN_BULLISH"
  },
  "research_recommendation": "BUY",
  "report": "\n======================================================================\nRISK MANAGER FINAL DECISION: JNJ\n======================================================================\n**Analysis Date:** 2024-10-03 (HISTORICAL)\n**Portfolio:** $100,000\n\n## VERDICT: MODIFY\n**Position:** 4.30% ($4,301.80)\n**Confidence:** MEDIUM\n\n## REASONING\nModifying our position in Johnson & Johnson (JNJ) to 4.30% is a strategic decision that capitalizes on the current oversold conditions and the company's robust earnings growth potential. With a high confidence rating from our research manager, the favorable risk/reward ratio positions JNJ as an attractive investment opportunity that is poised for recovery. This modification aligns perfectly with our bullish outlook based on strong fundamentals and technical indicators.\n\n## KEY FACTORS\n\u2022 strong earnings growth\n\u2022 favorable risk/reward ratio\n\u2022 current oversold conditions\n\n## EVALUATOR SUMMARY\n- Aggressive: HOLD @ 6.5%\n- Neutral: SMALL BUY @ 12%\n- Conservative: HOLD @ 0%\n\n## AGENT CONSENSUS\n- Bullish Votes: 2/4\n- Bearish Votes: 0/4\n- Neutral Votes: 2/4\n- Overall: Lean Bullish\n\n## POSITION SIZING\n- Range: 3.0% - 4.5%\n- Final: 4.30% ($4,301.80)\n\n## RISK CONTROLS\n- Stop Loss: -15%\n- Profit Targets: +12.5%, +18.8%, +25%\n\n## CONDITIONS\n\u2022 high confidence in recovery\n\u2022 positive technical indicators\n\n======================================================================\n"
}